VANCOUVER, British Columbia, March 28, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Wednesday, March 30, 2011 at 9:00 am Pacific Time (12:00 pm Eastern Time) to provide a corporate update and reports its 2010 audited operating results.
